Evidence mapPaperPMID 41683492Full record

ArticleMolecules (Basel, Switzerland)2026

A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (

Malliga R Iyer

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Malliga R IyerSection on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.ORCID 0000-0002-0116-4619

Funding

Novel Cannabinoid Receptor ModulatorsZIAAA000360 · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · 2025 to 2025
$1.4M
Intramural NIH HHS ZIA AA000360
6 · The paper itself

Abstract

Zevaquenabant (

Indexed as

Nitric Oxide Synthase Type IIReceptor, Cannabinoid, CB1HumansMolecular StructurePyrazolesStereoisomerismSulfur CompoundsMRI-1867Nitric Oxide Synthase Type IIPyrazolesReceptor, Cannabinoid, CB1Sulfur CompoundsCB1R CB2RECSiNOSMASHMPOPSASFC

Identifiers

PMID41683492
PMCPMC12899878

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.